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Experimental Paper
Seminal Plasma Annexin A5 Concentration is not Associated
with Male Subfertility and cannot be Influenced by Folic Acid
and Zinc Sulfate Treatment
ABSTRACT
Annexin A5 (anxA5) is abundantly present in seminal plasma, however, its endogenous
function in seminal plasma is not known. Recently, we demonstrated that folic acid and
zinc sulfate intervention increased sperm count. To explore the involvement of anxA5 in
human (sub)fertility, we measured anxA5 concentrations in seminal plasma, using sandwich
ELISA, before and after folic acid (5 mg/day) and zinc sulfate (66 mg/day) intervention
in 86 fertile and 78 subfertile males participating in a randomized placebo controlled
intervention study. Seminal plasma anxA5 concentrations at baseline were not significantly
different between fertile and subfertile males, (median) 5.2 µg/mL (25th–75th percentile:
4.2–7.2), and 5.6 µg/mL (4.3–6.7), respectively. The various treatments did not affect
seminal plasma anxA5 concentrations. In conclusion, seminal plasma anxA5 concentration
is not associated with male factor subfertility and the observed increase in sperm count
after folic acid and zinc sulfate treatment cannot be explained by a change in the seminal
plasma anxA5 concentration. Further studies are needed to elucidate the mechanisms
responsible for the beneficial effect of this intervention treatment on sperm count.
INTRODUCTION
Subfertility is a common disorder with a prevalence of about 15% in all couples in the
Western world.1-3 In about half the number of cases a male factor is identified, defined as
male factor subfertility. In most cases, subfertility is regarded as idiopathic, however,
gene-environment interactions are suggested to be involved.4 The environmental causes
are particularly of interest, because they are better amendable to curative and/or preventive
measures than genetic factors. A significant but largely neglected environmental factor is
nutrition. It is well known that nutrition plays an important role in reproduction.5 The
vitamin folate is known to contribute to the prevention of neural tube defects when taken
periconceptionally.6,7 Folate plays an important role in the synthesis of transport ribonucleic
acid (tRNA) and deoxyribonucleic acid (DNA) and methylation of proteins.
Zinc is an essential nutritional compound, serving as a cofactor for more than 80 metallo-
enzymes, and also as a cofactor in the synthesis of macromolecules such as DNA and
tRNA. It has been shown that zinc is essential in testicular development.8 Also, seminal
plasma zinc concentrations influence the oxygen consumption of spermatozoa,9,10 nuclear
chromatin condensation,11 acrosome reaction,12 and acrosin activity.13 Furthermore, the
synthesis of testosterone in the Leydig cells and the conversion of testosterone to 5α-dihydro-
testosterone by the 5α-reductase enzyme is dependent on zinc supply.14
Recently, we conducted an intervention study supplying both folic acid and zinc sulfate
to fertile and subfertile men, and found that after 26 weeks of intervention treatment,
subfertile men had a 74% increase in normal sperm count.15 Despite the knowledge that
zinc and folate are essential for the synthesis of genetic material, the precise underlying
mechanism by which these micronutrients affect spermatogenesis is not clear.
AnxA5 is a member of the protein family of annexins, which contains more than ten
members. These proteins (especially anxA5) are characterized by their high affinity for
negatively charged phospholipids present in cell membranes.16 AnxA5 is primarily known
because of its world-wide use to detect apoptosis in vitro and also experimentally in
vivo.17,18 Due to the affinity to negatively charged phospholipids, anxA5 is a potent
inhibitor of blood coagulation and inflammation.19 It is also known that anxA5 is abundantly
present in seminal plasma.20
Because our research group has not yet identified the underlying mechanism of the
beneficial effect of folic acid and zinc sulfate on spermatogenesis, and because of the
 
used in this test are affinity purified rabbit polyclonal antibodies specific for
human anxA5 (F(ab’)2 fragments) and an horse radish peroxidase coupled
affinity purified rabbit polyclonal antibody against anxA5. The substrate
used is ortho-phenylene diamine (OPD) in presence of hydrogen peroxide.
After color development adsorption is measured in a micro ELISA plate
reader at 492 nm (Easy reader, SLT Labinstruments Austria).
Quantitative real time AnxA5 RT-PCR. The seminal plasma anxA5
concentration may originate from different sites of synthesis, e.g., from
testis, prostate or seminal vesicles. To determine whether the prostate or the
testis is the main producer of anxA5, anxA5 messenger RNA (mRNA) was
measured and the anxA5 antigen was stained in human prostate and testis
sections. Complementary DNA (cDNA) was synthesized by using 1 µg
RNA of prostate tissue and testis (Clontech, Palo Alto). Testis mRNA was
isolated out of whole normal testes pooled from 45 Caucasians (age 14–64)
who deceased suddenly. Prostate mRNA was isolated from 47 Caucasians
(age 14–57) who also deceased suddenly. The mRNA was mixed with 625
µM dNTPs, 5 µg/ml random hexamer primer DTT, RNAsin (20 U) and
M-MLV RT (200 U) in a total volume of 15 µl to obtain cDNA. The
mixture was incubated for 10 min at 20˚C, followed by 45 min at 42˚C and
10 min at 95˚C. Primer-probe combinations for the anxA5 cDNA were
designed using PRIMER-EXPRESS software. De forward primer
CCACAGTCTGGTCCTGCTTC, the reverse primer AGTCACAGTGC-
CTCTGAGAACCT, and the minor groove-binding probe CTGACCT-
GAGTAGTCGC were mixed with 50 ng cDNA, 1.25 U AmpliTaq Gold
DNA polymerase with 250 µmol/l dNTPs. 1 X Taqman buffer A in a total
volume of 50 µl. Samples were heated at 95˚C for 10 min and amplified for
45 cycles of 15 sec at 95˚C and 60 sec at 60˚C (ABI/Prism 7700 Sequence
detector, Applied Biosystems). The expression of porphobilinogendeaminase
(PBGD), a low copy number housekeeping gene, was measured in duplicate
onto each sample to normalize for PCR and cDNA input variations.24 The
anxA5 mRNA concentrations were measured in duplicate and analyzed with
Taqman software. The results were expressed as delta cycle threshold (δCt)
in which δCt = Ct (PBGD) minus Ct (AnxA5). The relative difference in
expression is calculated by Comparative Ct method using the equation 2-δδCt.
Immunohistochemistry. Post mortem human paraffin-embedded
prostate and testis tissue sections were stained with a polyclonal antibody
directed against human anxA5. The sections were macroscopically and
microscopically checked by the pathologist as being normal prostate and
testis tissues. The sections were routinely processed to remove the paraffin
and to rehydrate the tissues. Next, the sections were blocked with human
serum albumin (0.1%) containing 50mM tris-buffered salt buffer, pH 7.4
(TBS/HSA) to which 20% normal swine serum was added. After 30 min
the sections were washed in TBS and incubated for another two hours with
a polyclonal antibody against human anxA5 (1000 X diluted in
TBS/HSA)(Hyphen Biomed, Andrésy, France). The sections were washed
again and incubated for 90 min with a biotin-conjugated swine anti-rabbit
polyclonal antibody (1000-fold diluted in TBS/HSA)(Dako, Glostrup,
Denmark). Finally, after washing the sections were incubated with alkaline
phosphatase-conjugated streptavidin-biotin complex (DakoCytomation,
Glostrup, Denmark) for 1 hour. After extensive washing the sections were
stained by using the alkaline-phosphatase substrate kit containing 2 mM
levamisole (Sigma, St Louis, MI) to block the endogenous alkaline
phosphatase activity, according to the manufacturers procedure (Vector,
Burlingame, CA, USA). The presence of anxA5 is notified by a red color.
The nucleus was counterstained blue with Mayer’s Haematoxylin (Merck,
Darmstadt, Germany).
Statistical analysis. The results were analyzed for statistical significance
using nonparametric tests, because of the skewed distributions of the deter-
minants. Concentrations of endogenous anxA5 are given as median and
25th–75th percentile. Baseline seminal plasma anxA5 concentrations were
compared between fertile and subfertile males using the Mann-Whitney U
test. The effect of the four interventions in fertile and subfertile males was
investigated by comparison between the baseline and post-intervention
seminal plasma anxA5 concentration by the Wilcoxon Signed Ranks test.
We corrected for a possible placebo-effect by comparing the delta anxA5
concentration for males receiving placebo with the delta anxA5 concentration
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Figure 1. Immunohistochemical staining with a polyclonal antibody directed
against Annexin A5 counterstained by Haematoxylin. Sections stained were
(A) seminiferous tubules of the testis (x 40) and (B) prostate (x 20). Annexin
A5 is stained red whereas the nucleus is blue. In the testis a gradual staining
of anxA5 was observed. The highest intensity is nearby the spermatocytes.
The spermatogonia are not stained. In the prostate mainly the glandular epithe-
lium is stained.
observation that anxA5 is abundantly present in seminal plasma, we
explored the possibility that endogenous anxA5 is directly involved
in male factor subfertility. Furthermore, we evaluated the effect of
intervention treatment with folic acid and zinc sulfate on anxA5
concentrations in seminal plasma.
MATERIALS AND METHODS
From the randomized, placebo controlled trial designed to study the
effect of folic acid and zinc sulfate on semen parameters,15,21 samples before
and after intervention from 86 fertile and 78 subfertile males were available
for the determination of endogenous anxA5 concentrations.
In the referred study, fertile males were recruited from nine midwifery
practices in the surrounding areas of Nijmegen, in The Netherlands. These
healthy men, without a history of fertility problems at the moment of
enrollment, had a pregnant partner who conceived spontaneously within
one year of regular, unprotected intercourse.
Subfertile males were recruited from the fertility clinics of the University
Medical Centre Nijmegen and the Canisius Wilhelmina Hospital in
Nijmegen. Subfertility was defined as failure of the female partner to conceive
after one year of regular, unprotected intercourse and a sperm concentration
between five and twenty million spermatozoa per mL on the first routine
semen analysis after referral to the fertility clinic. The females of these
subfertile males were not further evaluated, because the main focus was on
the effect of folic acid and zinc sulfate treatment on semen parameters in
subfertile males.
The fertile and subfertile males were included after having given their
written informed consent and assigned to the four intervention groups by
computer-generated random numbers. The interventions consisted of a
daily dose of folic acid (5 mg) and placebo, zinc sulfate (66 mg) and placebo,
or a combined dose of folic acid and zinc sulfate, or placebo/placebo
throughout 26 weeks.
Before and after intervention one standardized semen sample was
obtained from every participant for semen analysis according to World
Health Organization (WHO) guidelines.22 The semen samples were produced
by the participants via masturbation after an abstinence period of at least
three to five days. These samples were delivered within one hour after
production to the fertility laboratory. In this hour the participants were
advised to keep the sample at room temperature. After liquefaction, an
aliquot of semen was centrifuged at 1,400 x g (Hettich 16A, 1323 rotor) for
10 minutes. The supernatant seminal plasma was frozen without preserva-
tives and stored at -80˚C until assayed. Sperm concentration was determined
with a Makler counting chamber.
The Medical Ethical Committee and the Institutional Review Board of
the University Medical Centre Nijmegen approved of this trial.
AnxA5. The anxA5 concentration was investigated by sandwich
enzyme-linked immunosorbent assay (ELISA) (ZYMUTEST anxA5, Hyphen
BioMed, Andrésy, France) as described by van Heerde et al.23 The antibodies
A B
 
for males receiving the folic acid, zinc sulfate, or combined intervention
treatment. The p values were two tailed and p ≤ 0.05 was considered statis-
tically significant. Statistical analysis was performed using SPSS 10.0 for
Windows software (SPSS Inc, Chicago, IL, USA).
RESULTS
AnxA5 concentration in seminal plasma. Although anxA5 could be
determined in seminal plasma, it did not show an association with male
fertility. The median (25th–75th percentile) baseline seminal plasma anxA5
concentrations was 5.2 µg/mL (4.2–7.2) in fertile (Table 1A) and 5.6
µg/mL (4.3–6.7) in subfertile males (p = 0.96, (Table 1B).
Effect of intervention on seminal plasma AnxA5 concentration. Tables
1a and 1b show the effects of all interventions on seminal plasma anxA5
concentration in both fertile and subfertile males, respectively. We observed
no effect of the combination treatment with folic acid and zinc sulfate on
anxA5 concentration in both fertile and subfertile males (from 4.9 µg/mL
(3.6–7.1) to 3.4 µg/mL (1.8–6.6) in fertile males and from 5.6 µg/mL
(2.5–6.1) to 3.7 µg/mL (2.1–5.7) in subfertile males). All the other inter-
vention types (placebo, folic acid, and zinc sulfate intervention) also did not
significantly affect the anxA5 concentrations, neither in fertile, nor in
subfertile males.
AnxA5 site of synthesis. To get some global insight in the synthesis of
anxA5, the anxA5 mRNA concentrations and immunohistochemical local-
ization of anxA5 protein were determined. AnxA5 mRNA concentrations
appeared to be approximately twice as high in the prostate (δCt 5.0) as
compared to the testis (δCt 3.8). Furthermore, as shown in Figure 1,
immunohistochemical staining of anxA5 revealed strong staining in the
prostate and some staining in the testis. In the prostate mainly the glandu-
lar epithelium is stained. In the testis a gradual staining of anxA5 was
observed. The highest intensity is nearby the spermatocytes. The spermatogonia
are not stained.
DISCUSSION
This study was performed to explore if anxA5 is associated with
male factor subfertility and to find an underlying mechanism for the
intriguing observation that folic acid and zinc sulfate intervention
increases the sperm count in subfertile males.15,21 Remarkable was
the finding that the endogenous seminal plasma anxA5 concentrations
are at least 1000-fold higher compared to the concentrations of anxA5
in blood plasma of healthy volunteers, in which anxA5 concentrations
up to 5 ng/mL are found.23,25
The baseline seminal plasma anxA5 concentration, however, was
not significantly different between fertile and subfertile males. This
strongly suggests that it is not very likely that anxA5 is associated
with sperm concentration. Therefore, anxA5 is probably not involved
in male factor subfertility.
Our data suggest that anxA5 is not produced by the spermatozoa
themselves, since the immunohistochemical results indicate that the
spermatocytes themselves are not stained. Furthermore, the real time
mRNA analysis shows that the prostate is the most important organ
in the production of anxA5 in seminal plasma.
Only one other study could be found in which the authors inves-
tigated the concentration of anxA5 in seminal plasma. These authors
obtained semen samples from normal or vasectomized patients and
found anxA5 concentrations of approximately 20 µg/mL.20 It is
remarkable that these authors found an almost 4 times higher anxA5
concentration in seminal plasma compared to our findings. A possible
explanation for this difference in anxA5 concentration is the method
used to measure these concentrations. Christmas et al.20 pooled all
there seminal plasma, purified the annexins present in the seminal
plasma using an affinity column coated with phospholipids to which
the annexins bind, and thereafter used SDS-PAGE and immunoblot
analysis to determine if anxA5 was present in seminal plasma. The
concentrations of anxA5 in seminal plasma were estimated by com-
paring the immunostaining intensity of immunoreactive bands with
known standards of placental anxA5. In comparison to our ELISA
procedure the method used by Christmas et al.20 is only semi-
quantitative which may explain the higher yields of anxA5 from
seminal plasma. Christmas et al.20 further state that the annexins in
seminal plasma are actively secreted by the prostate, it being the
main producer of seminal plasma anxA5, which is in agreement with
our findings. They exclude the epididymis as a possible source of
annexin because the seminal plasma annexin concentrations are not
changed by vasectomy. This is consistent with our finding that the
anxA5 concentrations were not significantly different between fertile
and subfertile males at baseline.
The question remains what the possible link can be between
increases in sperm count in subfertile males after folic acid and zinc
sulfate intervention and the seminal plasma anxA5 concentration.
An interesting hypothesis is the effect of both nutrients on the control
of apoptosis. Spontaneous death of certain classes of germ cells has
been shown to be a constant feature of normal spermatogenesis in a
variety of mammalian species, including man.26,27 Scarce information
is available on the biological significance of apoptosis in spermato-
genesis or its possible role in male fertility.28 Since it is known that
endogenous anxA5 binds to apoptotic cells in vivo, possibly the
seminal plasma anxA5 concentration reflects the grade of apoptosis
of spermatozoa and other cell types involved in spermatogenesis and
seminal fluid production.
Annexin A5 and Sperm Count
94 Calcium Binding Proteins 2006; Vol. 1 Issue 2
Table 1B The effect of interventions on seminal
plasma annexin A5 concentrations (µg/mL)
in subfertile males
N Pre-intervention Post-intervention Delta
AnxA5 AnxA5
All (baseline) 78 5.6 (4.3–6.7) — —
Placebo 23 5.7 (4.3–7.6) 5.5 (2.6–8.9) -0.5 (-2.6–2.9)
Folic acid 16 5.4 (3.8–6.6) 5.2 (3.0–6.4) -0.01 (-1.7–1.2)
Zinc sulfate 18 5.2 (4.4–6.7) 4.9 (3.5–6.9) -1.1 (-2.0–1.6)
Folic acid and 21 5.6 (2.5–6.1) 3.7 (2.1–5.7) -0.4 (-1.6–0.9)
zinc sulfate
NB, data are the median (25th–75th percentile). Deltas are calculated as post-intervention-preintervention
value.
Table 1A The effect of interventions on seminal plasma 
annexin A5 concentrations (µg/mL)
in fertile males
N Pre-intervention Post-intervention Delta
AnxA5 AnxA5
All (baseline) 86 5.2 (4.2–7.2) — —
Placebo 21 5.2 (4.0–5.9) 5.2 (4.2–6.9) -0.5 (-1.1–1.6)
Folic acid 20 5.6 (4.3–7.6) 5.4 (3.7–7.2) -0.3 (-2.1–1.6)
Zinc sulfate 22 5.4 (4.3–8.1) 5.5 (3.2–6.9) -0.7 (-2.1–0.8)
Folic acid and 23 4.9 (3.6–7.1) 3.4 (1.8–6.6) -1.3 (-2.3–1.0)
zinc sulfate
NB, data are the median (25th–75th percentile). Deltas are calculated as post-intervention-preintervention
value.
                                            
Another possible link between seminal plasma anxA5 concentration
and sperm concentration is related to the function of anxA5 as an
inhibitor of inflammation. It is well known that subfertile men have
higher leukocyte numbers in their semen compared to their fertile
counterparts, the frequency of leukocytospermia (>106 white blood
cells/mL semen) being between 10–20% among infertile males.29
Sperm damage by white blood cells can amongst others be mediated
by proteases and cytokines, released during inflammation reactions.
Since anxA5 inhibits inflammation it could have a protective effect
in these situations, keeping sperm counts up.
In conclusion, the results presented in the present paper do not
support that anxA5 is associated with male factor subfertility.
Intervention with folic acid and zinc sulfate does not affect seminal
plasma anxA5 concentration. Therefore, it is not very likely that the
observed increase in sperm count after intervention can be attributed
to a possible decrease in apoptosis rate of cells involved in spermato-
genesis or protection to inflammation by endogenous seminal plas-
ma anxA5 concentration. Further research is needed to clarify the
underlying mechanisms responsible for the observed increase in
sperm count after folic acid and zinc sulfate intervention.
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